Primary outcome [evaluated at 12 months’ post implant] • Device acceptance (FPAS) Secondary outcomes [evaluated at 12 and 24 months’ post implant] • Health status (SF-12) • Patient empowerment (ICD-EMPOWER) • ICD concerns (ICDC) • Anxiety (GAD-7) • Depression (PHQ-9) • Health status (KCCQ-12; for patients with heart failure only) • Return to work • Time to first ICD therapy defined as anti-tachycardia pacing, cardioversion or shock • Time to first hospitalisation due to a cardiac cause • Mortality • Cost of intervention program • Healthcare costs • Labour market absence • Cost-effectiveness (i.e., incremental cost gained per quality adjusted life year (QALY) and burden on health care professionals (physicians and nurses)a |